Clinical Trial Update: CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 crossover trial of motor cortex stimulation for intractable neuropathic pain (facial pain) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Pain
• Pain Intractable

Snippet

Sponsor: MedtronicNeuro | Conditions: Pain, Intractable, Facial Pain | Phase 3 | Status: TERMINATED